Definition, Epidemiology, and Pathogenesis

被引：0

作者：

Sala-Cunill A. ^{[1
,2
]}

Cardona V. ^{[1
,2
]}

机构：

[1] Allergy Section, Department of Internal Medicine, Hospital Universitari Vall d’Hebron, Barcelona

[2] Allergy Research Unit, Allergy Department, Institut de Recerca Vall d’Hebron, Universitat Autonoma de Barcelona, Passeig Vall d’Hebron 119-129, Barcelona

来源：

Current Treatment Options in Allergy | 2015年 / 2卷 / 3期

关键词：

Anaphylaxis; Epidemiology; Incidence; Mast cell; Prevalence; Risk factors; Severity; Tryptase;

D O I：

10.1007/s40521-015-0053-1

中图分类号：

学科分类号：

摘要：

Anaphylaxis is a severe reaction that is rapid in onset and may lead to death. The prevalence of anaphylaxis seems to be increasing. However, knowledge about the epidemiology of anaphylaxis is based on data from various sources: clinical practice, large secondary clinical and administrative databases of primary care or hospitalized patients, and recent surveys with representative samples of the general population. The different inclusion criteria, settings, geographic area, and time at which these studies are performed may explain the huge difference in prevalence, incidence, and triggers. Nevertheless, it is clear that the incidence and prevalence of anaphylaxis are higher than previously thought. Publications from the last 5 years reveal an incidence of between 12.8 and 112 episodes per 100,000 person-years. Furthermore, depending on the trigger of anaphylaxis, the symptoms of the reaction could differ enormously, the mechanism initiating the anaphylactic reaction, and the effector cells involved; therefore, the biomarkers may differ according to these factors. However, many of these data are missing in epidemiologic studies. Thus, in order to increase the knowledge of anaphylaxis, there is a need to improve epidemiologic research standardizing information provided, as summarized in this review. © 2015, Springer International Publishing AG.

引用

页码：207 / 217

页数：10

共 55 条

[1] Sampson H.A., Munoz-Furlong A., Campbell R.L., Adkinson N.F., Bock S.A., Branum A., Et al., Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium, J Allergy Clin Immunol, 117, pp. 391-397, (2006)
[2] Simons F.E., Ardusso L.R., Bilo M.B., Dimov V., Ebisawa M., El-Gamal Y.M., Et al., Update: world allergy organization guidelines for the assessment and management of anaphylaxis, Curr Opin Allergy Clin Immunol, 2012, 12, pp. 389-399, (2012)
[3] Kemp S.F., Lockey R.F., Anaphylaxis: a review of causes and mechanisms, J Allergy Clin Immunol, 110, pp. 341-348, (2002)
[4] Simons F.E.R., Ardusso L.R., Bilo M.B., Cardona V., Ebisawa M., El-Gamal Y.M., Et al., International consensus on (ICON) anaphylaxis, World Allergy Organ J, 7, 9, (2014)
[5] Simons F.E.R., Ardusso L.R.F., Bilo M.B., Dimov V., Ebisawa M., El-Gamal Y.M., Et al., World Allergy Organization Guidelines for the assessment and management of anaphylaxis, World Allergy Organ J, 4, pp. 13-37, (2011)
[6] Muraro A., Roberts G., Worm M., Bilo M.B., Brockow K., Fernandez Rivas M., Et al., Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology, Allergy, 69, pp. 1026-1045, (2014)
[7] Panesar S.S., Nwaru B.I., Hickstein L., Rader T., Hamadah H., Ali D.F.I., Et al., The epidemiology of anaphylaxis in Europe: protocol for a systematic review, Clin Transl Allergy, 3, (2013)
[8] Brown A.F.T., McKinnon D., Chu K., Emergency department anaphylaxis: a review of 142 patients in a single year, J Allergy Clin Immunol, 108, pp. 861-866, (2001)
[9] Smit D.V., Cameron P.A., Rainer T.H., Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions, J Emerg Med, pp. 381-388, (2005)
[10] Braganza S.C., Acworth J.P., Mckinnon D.R.L., Peake J.E., Brown A.F.T., Paediatric emergency department anaphylaxis: different patterns from adults, Arch Dis Child, 91, pp. 159-163, (2006)

← 1 2 3 4 5 6 →